title: EHDP-induced rachitic syndrome in rats is not reversed by vitamin D metabolites.
abstract: To examine whether either of the two known active vitamin D metabolites 1,25(OH)2D3 or 24,25(OH)2D3 could reverse the mineralization defect induced by 1-hydroxyethylidene-1,1-bis phosphonate (EHDP), a model of EHDP-induced rickets was used. Rats at the age of 31 days were injected for 10 consecutive days with EHDP (10 mg/kg). Other littermates were treated with a combination of EHDP and either 1,25(OH)2D3 or 24,25(OH)2D3 or were treated following 10 days of EHDP, with either of the vitamin D metabolites for an additional 72 hr. Samples of cartilage fluid (Cfl) and of blood were removed prior to sacrifice for biochemical studies of some parameters of calcification. These parameters were correlated with the results of light and electron microscope studies of growth plate cartilage and bone. EHDP-treated rats revealed signs of typical rickets, manifested by widened growth plates and impaired bone mineralization. Transmission electron microscope (TEM) examination revealed matrix vesicles distributed throughout the growth plate; however, there appeared to be an arrest of the spread of the crystals at the provisional zone of calcification. Treatment with either 1,25(OH)2D3 or 24,25(OH)2D3 failed to reverse the rachitic condition of the animals. Serum calcium blood levels were elevated in the 1,25(OH)2D3 and EHDP-treated group. 1,25(OH)2D3 and 24,25(OH)2/D3 further increased the already elevated serum alkaline phosphatase levels observed in EHDP rats, although the increase observed with 1,25(OH)2D3 was not statistically significant.(ABSTRACT TRUNCATED AT 250 WORDS)
mesh_terms: D000818:Animals; D002113:Calcification, Physiologic / Q000187:drug effects; D004100:Dihydroxycholecalciferols / Q000494:pharmacology / Q000627:therapeutic use*; D012968:Etidronic Acid; D006132:Growth Plate / Q000473:pathology; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012279:Rickets / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology
chemical_list: D004100:Dihydroxycholecalciferols; D012968:Etidronic Acid